A new 3D model shows that Duchenne gene therapy can repair muscle fibers but fails to shut down the signals that drive ...

Because technology is a part of columnist Shalom Lim's daily life with Duchenne muscular dystrophy, he weighs in on the ...

Researchers identified a molecular pathway that can limit muscle repair, a finding that may guide future muscular dystrophy treatments.

Roche has decided to stop developing satralizumab for bone health in Duchenne muscular dystrophy, the company announced.

The president and CEO of the Muscular Dystrophy Association talks about what she's most excited about in neuromuscular disease research.

After following the Olympics, columnist Robin Stemple envisions a future with new treatments and even a cure for FSHD.

After years of focusing on her large family, and three sons with Duchenne MD, columnist Betty Vertin is eager to reconnect with friends.

Columnist Patrick Moeschen turns to classic writers and poets to express how he is choosing hope in life with limb-girdle muscular dystrophy.

Dosing has begun in a Phase 2 clinical trial testing the experimental oral therapy SAT-3247 in boys with Duchenne muscular dystrophy (DMD).

Rob Stemple is a lifelong advocate for people with disabilities. He was diagnosed with FSHD in 1971 at age 14. Rob struggled with its’ affects for over 50 years. He lost his eyesight in a devastating ...

Columnist Shalom Lim has discovered that a personal sense of belonging is built through simple presence. Art can help foster that growth.

Histone deacetylase inhibitors are a treatment approach designed to work by blocking an enzyme that turns off gene activity. This may ultimately help by slowing muscle loss and disease progression.